epithalon capsules Epitalon: What can this peptide do for telomere protection, aging, and longevity, and where is the evidence? Epithalon (AEDG) Telomerase & Epigenetic

NIVs polypharmacology strategy repurposes approved drugs via the FDAs 505(b)(2) pathway, leveraging existing safety data to reduce time, cost, and development risk

Research suggests DSIP may promote slow-wave (deep) sleep, which supports recovery, hormone regulation, and cognitive function

Key Takeaways Dihexa's plasma half-life of 24 hours doesn't dictate dosing frequency because downstream synaptic changes persist 714 days after administration, substantially longer than compound detection in circulation

Recent data indicates that the median time from NDA/BLA submission to FDA approval is approximately 12 months for standard review applications, with about 75-80% of drugs ultimately approved after their first review cycle

Retatrutide does not stop working for the vast majority of users